NKAP anticorps (N-Term)

N° du produit ABIN6263641

Cet anticorps anti-NKAP est un anticorps Lapin Polyclonal détectant NKAP dans WB, ELISA et IHC. Adapté pour Humain, Rat et Souris.

Aperçu rapide pour NKAP anticorps (N-Term) (ABIN6263641)

Antigène: NKAP (NFKB Activating Protein (NKAP))

Reactivité: Humain, Rat, Souris

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp NKAP est non-conjugé

Application: Western Blotting (WB), ELISA, Immunohistochemistry (IHC)

Détail du produit anti-NKAP anticorps

Épitope: N-Term

Specificité: NKAP Antibody detects endogenous levels of total NKAP.

Homologie: Rabbit

Purification: The antiserum was purified by peptide affinity chromatography using SulfoLink^TM Coupling Resin (Thermo Fisher Scientific).

Immunogène: A synthesized peptide derived from human NKAP, corresponding to a region within N-terminal amino acids.

Isotype: IgG

Information d'application

Indications d'application: WB 1:1000-3000, IHC 1:50-1:200, ELISA(peptide) 1:20000-1:40000

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 mg/mL

Buffer: Rabbit IgG in phosphate buffered saline , pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20 °C. Stable for 12 months from date of receipt.

Date de péremption: 12 months

Détails sur NKAP

Antigène: NKAP (NFKB Activating Protein (NKAP))

Autre désignation: NKAP

Sujet:

Description: Acts as a transcriptional repressor. Plays a role as a transcriptional corepressor of the Notch-mediated signaling required for T-cell development. Also involved in the TNF and IL-1 induced NF-kappa-B activation. Associates with chromatin at the Notch-regulated SKP2 promoter.

Gene: NKAP

Poids moléculaire: 47 kDa

ID gène: 79576

UniProt: Q8N5F7

Pathways: Stem Cell Maintenance, Phosphorylation & l'infection par le SRAS-CoV-2